Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature.
Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL.
Iriarte C, et al. Among authors: oza vs.
Support Care Cancer. 2024 Aug 23;32(9):610. doi: 10.1007/s00520-024-08810-x.
Support Care Cancer. 2024.
PMID: 39174797
Review.